Benzene

Benzene

SCHEMBL14717513

I.I.I.c1ccccc1.c1ccccc1.c1ccccc1

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Benzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.75
TP53 P04637 1/20 0.75
ALDH1A1 P00352 1/20 0.30
NAPRT Q6XQN6 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL27481209 1.00 TSHR (0.75) TSHRTP53ALDH1A1NAPRTTDP1
Benzene SCHEMBL10754293 1.00 TSHR (0.75) TSHRTP53ALDH1A1NAPRTTDP1
Benzene SCHEMBL27467285 1.00 TSHR (0.75) TSHRTP53ALDH1A1NAPRTTDP1
Benzene SCHEMBL14717514 1.00
Benzene SCHEMBL3066045 1.00
Benzene SCHEMBL4344056 1.00
Benzene SCHEMBL7398811 0.89
Benzene SCHEMBL9585165 0.89
Benzene SCHEMBL14954166 0.89
Benzene SCHEMBL29207559 0.89 TP53 (0.60) TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103922956-A Continuous Crystallisation Process Of Iodinated Phenyl Derivatives GE HEALTHCARE AS 2014-07-16 CN claimed
CN-101233092-A Continuous crystallization method of iodinated phenyl derivatives GE HEALTHCARE AS (NO) 2008-07-30 CN claimed
CN-101171030-A Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions BAUSCH & LOMB (US) 2008-04-30 CN claimed
CN-101679152-B Method of preparing iodinated aromatic compounds SK CHEMICALS CO LTD 2014-08-06 CN disclosed
EP-2564875-A1 LIQUID PREPARATION FOR ORAL ADMINISTRATION WHICH CAN BE USED IN CT COLONOGRAPHY, AND COMPOSITION FOR IMAGING OF DIGESTIVE TRACT Ajinomoto Co., Inc. (JP) 2013-03-06 EP disclosed
US-20130052143-A1 LIQUID PREPARATION FOR ORAL ADMINISTRATION TO BE USED IN CT COLONOGRAPHY, AND COMPOSITION FOR DIGESTIVE TRACT IMAGING AJINOMOTO CO., INC. (JP) 2013-02-28 US disclosed
CN-101679152-A Method of preparing iodinated aromatic compounds SK CHEMICALS CO LTD 2010-03-24 CN disclosed
CN-1946356-A Systems and methods for forming identifiable structures in a solid freeform fabrication system HEWLETT PACKARD DEVELOPMENT CO (US) 2007-04-11 CN disclosed